EP4719440A1 — Compositions of blood plasma fractions and blood plasma subfractions and their use in treatment of disease
Assigned to Grifols Worldwide Operations Ltd · Expires 2026-04-08 · 0y expired
What this patent protects
Methods and compositions for treating and/or preventing disease are described. The compositions used in the methods include fractions and subfractions of blood plasma derived from donors, with efficacy in treating and/or preventing diseases both of the central nervous system and …
USPTO Abstract
Methods and compositions for treating and/or preventing disease are described. The compositions used in the methods include fractions and subfractions of blood plasma derived from donors, with efficacy in treating and/or preventing diseases both of the central nervous system and peripheral organs and tissues. Methods of manufacturing the compositions are also described.
Drugs covered by this patent
- Agamree (VAMOROLONE) · Catalyst Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.